相关实验视频

Updated: Jul 4, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

微RNA与骨瘤的关联:未来的治疗途径

Rashid Al-Shibli¹, Mohammed AlSuleimani¹, Ibrahim Ahmed¹

¹Department of Medical, Sultan Qaboos University Hospital, Muscat, 123, Oman.

Current medicinal chemistry

|February 1, 2024

概括

微核糖核酸 (miRNAs) 调节基因,并与骨瘤有关. 了解miRNA变化对于诊断,治疗和开发治疗骨癌的药物至关重要.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

微核糖核酸 (miRNAs) 是小型非编码RNAs,可以在转录后调节基因表达.
改变的miRNA表达与包括骨瘤在内的各种疾病的发展和进展有关.
骨瘤,如骨髓瘤和巨细胞瘤,按矩阵生产和细胞类型进行分类.

研究的目的:

审查miRNAs在骨瘤的发病,诊断和预后中的作用.
讨论特定的miRNAs与常见的骨癌,如骨髓瘤,尤文肉瘤,软骨瘤和巨细胞瘤之间的关联.
探索miRNA失调作为治疗标和骨瘤学的预后生物标记物的潜力.

主要方法:

对调查骨瘤中miRNA表达的研究进行文献综述.
分析miRNAs作为瘤抑制剂或在骨瘤中瘤基因的功能性作用.
综合当前关于miRNA参与骨瘤扩散,生长和转移的知识.

主要成果:

miRNAs可以作为瘤抑制剂或瘤基因,影响瘤命运.
特定的miRNA与各种骨瘤有关,影响其预后和发病.
miRNA失调,放大或删除与骨癌的发展和进展有关.

结论:

miRNAs在骨瘤生物学中发挥着重要作用,包括扩散,生长和转移.
了解miRNA配置文件可以帮助诊断和预测骨瘤的预后.
针对miRNAs提供了新的治疗策略和药物设计的潜力,用于骨癌,包括耐药病例.

关键词:

骨的瘤骨的瘤骨癌. 骨癌. 骨癌. 骨癌. 骨癌. 骨癌. 骨癌. 骨癌.圣经法典的路径.这就是miRNAs.抑制剂基因抑制剂的基因治疗剂治疗剂治疗剂

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...